NCT03961347View on ClinicalTrials.gov

Lactobacillus Johnsonii Supplementation in Adults With T1D

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions
Type 1 Diabetes (T1D)
Interventions
DRUG

L. johnsonii Probiotic

Participants will consume one capsule of L. johnsonii probiotic daily for 24 weeks.

DRUG

Placebo Capsule

Participants will consume one capsule of placebo capsule of dried skim milk daily for 24 weeks.

Trial Locations (1)

32610

UF Clinical Research Center, Gainesville

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Florida

OTHER